Rabies

At the end of this course, you will be able to:

• Explain the transmission, symptoms and clinical management of rabies 
• Specify the importance of different animal reservoirs in the spread of the virus 
• Describe human and animal vaccination strategies to combat rabies virus
• Identify the role of international organizations in rabies elimination
• Discuss rabies control strategies in different regions of the world 

Course plan

Chapter 1 – Introduction

• C1.1 : General introduction and history / Hervé BOURHY (IPP, France)
• C1.2 : Rabies virus and lyssaviruses: structure, replication, virus-host cell interactions / Noel TORDO (IPGui, Guinea)

Chapter 2 - Rabies (transmission, clinical pictures, management and diagnosis)

• C2.1 : Rabies in dogs / Jesse BOMWITT (Durham University - UK)
• C2.2 : Rabies in humans / Beatriz QUIAMBAO (Research Institute for Tropical Medicine (RITM), the Philippines)
• C2.3 : Diagnosis in animals / Paola DE BENEDICTIS (IZSVe, Italy)
• C2.4 : Diagnosis in humans / Laurent DACHEUX (IPP, France)

Chapter 3 - Epidemiology of animal and human rabies

• C3.1 : Dog ecology and role of the dogs as main reservoir of rabies / Véronique CHEVALIER (CIRAD/IPM, Madagascar)
• C3.2 : Role of wildlife carnivores / Cécile TROUPIN (IPC, Cambodia)
• C3.3 : Role of bats, Jordi SERRA-COBO (University of Barcelona, Spain)
• C3.4 : Global epidemiology of human rabies / Katie HAMPSON (University of Glasgow, UK)

Chapter 4 - Rabies vaccines & human and animal vaccine strategies

• C4.1 : Anti-rabies immune responses / Tineke CANTHAERT (IPC, Cambodia)
• C4.2 : Human rabies vaccines / Lucille BLUMBERG (University of Pretoria, South Africa)
• C4.3 : Animal rabies vaccines / Ryan WALLACE (CDC, USA)
• C4.4 : Vaccination in humans (pre- and post-exposure) / Arnaud TARANTOLA (Santé Publique France, France)
• C4.5 : Implementation of PEP in developing countries: the example of Cambodia / Sowath LY (IPC, Cambodia)
• C4.6 : Vaccination in dogs / Florence CLIQUET (ANSES, France)
• C4.7 : Rabies control strategies at the example of Africa / Jakob ZINSSTAG (Swiss TPH, Switzerland)

Chapter 5 - Prophylactic and therapeutic perspectives

• C5.1 : Development of new rabies vaccines / Charles RUPPRECHT (LYSSA LLC, USA)
• C5.2 : Drugs strategies / Noel TORDO (IPGui, Guinea)
• C5.3 : Monoclonal antibodies / Hervé BOURHY (IPP, France)

Chapter 6 : Towards the elimination of human rabies: Role of International Organizations

• C6.1 : As we step closer: The “Zero by 30” rabies elimination strategy / Bernadette ABELA-RIDDER (WHO, Switzerland)
• C6.2 : The role of international organisations in reaching “Zero by 30” / Rachel TIDMAN (OIE, France)
• C6.3 : Work of the Food and Agriculture Organisation of the United Nation (FAO) on Rabies: Contributing to “0 by 30” / Katinka De Balogh (FAO, Italy)
• C6.4 : Communication and community participation / Louis NEL (GARC, South Africa)

Chapter 7 - Some examples of field stories

• C7.1: Oral vaccination from foxes to dogs / Thomas MULLER (FLI, Germany)
• C7.2: Rabies situation in the Americas / Marco VIGILATO (PAHO, USA)
• C7.3 : Rabies situation in India and elimination issues in Asia / Reeta S. MANI (NIMHANS, India)
• C7.4: Example of Morocco / Oussama DEHHANI (ONSSA, Morocco)
• C7.5: Example of KwaZulu- Natal, South Africa / Kevin LEROUX (Kwazulu Natal Department of Agriculture, South Africa)